Sarepta snags its partner’s CSO, Louise Rodino-Klapac, to lead new gene therapy unit – Endpoints News
Endpoints News |
Sarepta snags its partner's CSO, Louise Rodino-Klapac, to lead new gene therapy unit
Endpoints News Putting one more arrow in its muscular dystrophy quiver, Sarepta has snagged a top executive from one of its partners to lead the company's newly-created gene therapy unit. Louise Rodino-Klapac is coming on board as vice president of gene therapy. |
